These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2119546)

  • 41. Evaluation of safety, efficacy, and acceptability of NORPLANT implants in Sri Lanka.
    Basnayake S; Thapa S; Balogh SA
    Stud Fam Plann; 1988; 19(1):39-47. PubMed ID: 3129828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Three-year experience with NORPLANT subdermal contraception.
    Sivin I; Sanchez FA; Diaz S; Holma P; Coutinho E; McDonald O; Robertson DN; Stern J
    Fertil Steril; 1983 Jun; 39(6):799-808. PubMed ID: 6406273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
    Olsson SE; Odlind V; Johansson ED; Nordström ML
    Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experience of Thai women in Bangkok with Norplant-2 implants.
    Chompootaweep S; Kochagarn E; Tang-Usaha J; Theppitaksak B; Dusitsin N
    Contraception; 1998 Oct; 58(4):221-5. PubMed ID: 9866003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
    Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
    Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective study on the effects of reformulated 2-rod Norplant implant on haemostasis after five years of use.
    Koh SC; Viegas OA; Ratnam SS
    J Obstet Gynaecol Res; 1999 Jun; 25(3):177-83. PubMed ID: 10467790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Five-year experience with Norplant.
    Affandi B; Santoso SS; Djajadilaga ; Hadisaputra W; Moeloek FA; Prihartono J; Lubis F; Samil RS
    Contraception; 1987 Oct; 36(4):417-28. PubMed ID: 3127111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Depressive symptoms and Norplant contraceptive implants.
    Westhoff C; Truman C; Kalmuss D; Cushman L; Rulin M; Heartwell S; Davidson A
    Contraception; 1998 Apr; 57(4):241-5. PubMed ID: 9649915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants.
    Díaz S; Croxatto HB; Pavez M; Belhadj H; Stern J; Sivin I
    Contraception; 1990 Jul; 42(1):97-109. PubMed ID: 2117517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Norplant: a new contraceptive.
    Flattum-Riemers J
    Am Fam Physician; 1991 Jul; 44(1):103-8. PubMed ID: 1905473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Norplant in The Netherlands].
    Braat DD; Hateboer N; Bleker OP; Kroes H
    Ned Tijdschr Geneeskd; 1990 Mar; 134(11):543-4. PubMed ID: 2108335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attitudes towards contraceptive implants and injectables among present and former users in Singapore.
    Singh K; Viegas OA; Ratnam SS
    J Biosoc Sci; 1990 Jan; 22(1):1-11. PubMed ID: 2105323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of Norplant implants in Shanghai: three-year experience.
    Du MK; Zheng HM; Chen HC; Chow LP
    Int J Gynaecol Obstet; 1990 Dec; 33(4):345-57. PubMed ID: 1979289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in carbohydrate metabolism during 30 months on Norplant.
    Konje JC; Otolorin EO; Ladipo OA
    Contraception; 1991 Aug; 44(2):163-72. PubMed ID: 1909945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
    Sivin I; Lähteenmäki P; Mishell DR; Alvarez F; Diaz S; Ranta S; Grozinger C; Lacarra M; Brache V; Pavez M; Nash H; Stern J
    Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls.
    Sivin I; Viegas O; Campodonico I; Diaz S; Pavez M; Wan L; Koetsawang S; Kiriwat O; Anant MP; Holma P; el din Abdalla K; Stern J
    Contraception; 1997 Feb; 55(2):73-80. PubMed ID: 9071515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Norplant on mothers and infants in the postpartum period.
    Affandi B; Karmadibrata S; Prihartono J; Lubis F; Samil RS
    Adv Contracept; 1986 Dec; 2(4):371-80. PubMed ID: 3105266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.